# US 2026/0137928 A1 · Devices and methods for transferring power to implanted medical devices

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0137928 A1
- Document ID: US20260137928A1
- Status: Published application
- Kind: A1
- Application number: 19/389,463
- Filed: 2025-11-14
- Published: 2026-05-21
- Earliest claimed: 2021-07-01
- Assignees: Corisma Cardiovascular
- Applicants: Corsima Cardiovascular
- Inventors: Michael Edward Theran; Jim Kelley; Mark Kelley; Orhan Soykan
- Web page: https://patentgrep.com/patent/US20260137928A1

## CPC

- A61M 60/873: specially adapted for wireless or transcutaneous energy transfer [TET], e.g. inductive charging
- A61M 60/875: specially adapted for optimising alignment of external and implantable coils
- A61M 60/148: in line with a blood vessel using resection or like techniques, e.g. permanent endovascular heart assist devices
- A61M 60/165: implantable in, on, or around the heart
- A61M 60/17: inside a ventricle, e.g. intraventricular balloon pumps
- A61M 60/237: the blood flow through the rotating member having mainly axial components, e.g. axial flow pumps
- A61M 60/242: with the outlet substantially perpendicular to the axis of rotation
- A61M 60/857: Implantable blood tubes
- A61M 2205/3569: sublocal, e.g. between console and disposable
- A61M 2209/088: on the body
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Systems, devices and methods are provided for supporting cardiac function. One system comprises an implantable intracardiac device comprising a motor and a pump, a transmitting resonator comprising a magnetic coil and configured to transmit a first level of power through an outer skin surface of the patient and a receiving resonator configured for implantation within the patient, comprising a magnetic coil and configured to transmit a second level of power to the motor within the implanted device. A controller is coupled to the transmitting resonator and configured to control the resonators and other parameters in the system such that the second level of power remains at or above a threshold level, thereby ensuring that the pump will continuously pump blood through the heart at a sufficient rate regardless of any changes in the system, such as power loss due to transmission inefficiencies and/or changes in the relative positions between the transmitting and receiving coils.

## Claims

### Claim 1

A system for supporting cardiac function in a patient, the system comprising:
an implantable device comprising:
a housing having first and second ends, an internal surface, a first inlet for blood disposed between the first and second ends and an outlet spaced longitudinally from the first inlet, the first inlet and the outlet defining a primary flow path through the housing;
a rotor disposed within the housing and spaced from the internal surface to define a clearance therebetween;
an impeller coupled to the rotor for impelling blood from the first inlet to the outlet of the housing; and
a second inlet for blood within the housing fluidly coupled to the clearance between the rotor and the housing to define a secondary flow path through the clearance.
a transmitting resonator-configured to transmit a first level of power through an
outer skin surface of the patient; and
a receiving resonator configured for implantation within the patient, the receiving
resonator being configured to transmit a second level of power to the motor.

### Claim 2

(canceled)

### Claim 3 (depends on 1)

The system of claim 1, wherein the secondary flow path at least partially resists
axial forces applied by the impeller or the rotor.

### Claim 4 (depends on 1)

The system of claim 1, wherein the secondary flow path at least partially resists
radial forces applied by the impeller or the rotor.

### Claim 5 (depends on 1)

The system of claim 1, wherein the secondary flow path provides a fluid bearing
between the rotor and the housing.

### Claim 6 (depends on 1)

The system of claim 1, wherein the second inlet is disposed between the first
and second ends of the housing.

### Claim 7 (depends on 1)

The system of claim 1, wherein the second inlet is disposed at, or near, the first
end of the housing and the outlet is disposed at, or near, the second end of the housing.

### Claim 8 (depends on 1)

The system of claim 1, further comprising a fluid pressure element in the secondary flow path.

### Claim 9 (depends on 8)

The system of claim 8, wherein the fluid pressure element comprises a surface extending in a lateral direction relative to a longitudinal axis of the housing.

### Claim 10 (depends on 9)

The system of claim 9, wherein the rotor comprises a substantially cylindrical
outer surface and wherein the fluid pressure element comprises an enlarged portion having a larger diameter than the rotor.

### Claim 11 (depends on 1)

The system of claim 1, wherein the rotor comprises a substantially cylindrical outer surface and one or more variable pressure surfaces on the outer surface configured to resist radial forces.

### Claim 12 (depends on 11)

The system of claim 11, wherein at least a portion of the variable pressure surfaces are recessed from the outer surface of the rotor and wherein the variable pressure surfaces are circumferentially spaced from each other around the outer surface of the rotor.

### Claim 13

A system for supporting cardiac function in a patient, the system comprising:
an implantable device comprising a pump, the pump comprising:
an elongate housing having first and second ends, an internal surface, an inlet for
blood disposed between the first and second ends and an outlet spaced longitudinally from the first inlet;
a rotor disposed within the housing and spaced from the internal surface to define a clearance therebetween;
an impeller coupled to the rotor for impelling blood from the inlet to the outlet of the housing; and
a fluid bearing suspending the impeller and the rotor within the housing;
a transmitting resonator-configured to transmit a first level of power through an
outer skin surface of the patient; and
a receiving resonator configured for implantation within the patient, the receiving
resonator being configured to transmit a second level of power to the motor.

### Claim 14 (depends on 13)

The system of claim 13, wherein the rotor and the impeller are spaced from the
internal surface of the housing and at least partially supported with hydrodynamic forces within the housing.

### Claim 15 (depends on 13)

The system of claim 13, wherein the fluid bearing comprises one or more surfaces that create a fluid pressure that resists axial forces generated by the impeller or the rotor.

### Claim 16 (depends on 13)

The system of claim 13, wherein the fluid bearing comprises one or more surfaces that create a fluid pressure that resists radial forces generated by the impeller or the rotor.

### Claim 17 (depends on 13)

The system of claim 13, wherein the housing defines a primary blood flow path
between the inlet and the outlet, and further comprising a second inlet for blood within the housing fluidly coupled to the clearance between the rotor and the housing to define a secondary flow path through the clearance.

### Claim 18 (depends on 17)

The system of claim 17, wherein the secondary blood flow path is in a substantially opposite direction as the primary blood flow path.

### Claim 19 (depends on 13)

The system of claim 13, wherein the primary blood flow path has a first mass flow rate and the secondary blood flow path has a second mass flow rate, wherein the second mass flow rate is about 1% to about 20% of the first mass flow rate.

### Claim 20 (depends on 19)

The system of claim 19, wherein the second mass flow rate is about 5% to about 10% of the first mass flow rate.
